Introduction
Patients suffering from osteoarthritis of the knee are characterized by increasing pain, reduced function and decreasing range of motion. When all conservative treatment options have been exhausted, patients typically receive a total knee arthroplasty (TKA) if clinically justified.
However, 16% of primary knee replacement patients rate their satisfaction as poor or fair and up to 25% of patients have anterior knee pain following TKA. 1, 2 Beverland reports long-term discrepancies between the outcomes of total hip arthroplasty and TKA: 55% of hip replacement patients achieved positive results after 10 years, whereas only in 4% of TKA patients positive long-term results, ie resulting in a "forgotten" knee, could be observed. 3 Approaches to improve the situation have to address several aspects, as factors influencing the outcomes of a TKA procedure are multifactorial including patient demographics, comorbidities, the hospital setting, surgical process (ie the instruments that help surgeons implant total knee devices), implant design and recovery principles. 4 Furthermore streamlining of both the TKA treatment as well as the recovery process is required to reduce utilization of health-care resources and to meet increasing patient demand for improved functioning. 5 The ATTUNE ® Knee System (DePuy Synthes, Warsaw, IN, USA) has been designed to accommodate patient variation, soft tissue interaction and to optimize patella tracking. 6 Amongst other features a gradually reducing femoral radius allows for a smooth transition during knee bending to produce high stability of the knee by minimizing unnatural sliding of the femur on the tibia. 7 First clinical studies and registry results comparing the ATTUNE knee and other knee systems indicate clinically relevant improvements in a wide range of patient-reported outcomes and confirm surgeons' reports of less pain, increased range of motion and earlier mobility with the ATTUNE Knee System. 8, 9 The economic burden associated with osteoarthritis is substantial and increasing. In Germany expenditures for osteoarthritis (ICD-10 M15-M19) accrued to €7.62 billion in 2008. 10 Osteoarthritis is the main cause for a primary TKA accounting for 96% of all cases. 10 Whilst these surgeries are considered highly cost effective and clinically beneficial they result in an average inpatient cost of €7,106 per patient to be borne by the statutory health insurance. 11 In Germany, the number of TKAs performed has consistently increased since early 2000, with 173,304 TKAs performed in 2015, making knee joint replacement among the 20 most common hospital procedures in Germany. 12 Due to changes in demography as well as morbidity, such as the aging society or increasing prevalence of obesity, the overall incidence of TKA is expected to rise further in the coming decades even in conservative estimate scenarios. 13 Hospitals are subject to strong cost pressures and pursue several measures in an effort to contain costs. In US settings some of the rising costs in TKA surgery could be offset by reducing length of stay (LOS) as one of the major cost drivers.
14 Also in Germany the reduction in length of hospitalization is one of the key cost-controlling factors. To our knowledge no published LOS analyses are available for the German setting. Hence, the objective of this study was to analyze the potential impact on LOS after the introduction of the ATTUNE Knee System in a German hospital.
Methods
Our analysis is based on a single center chart review of the hospital controlling system of a single surgeon team and applied a retrospective cohort study design, where the type of knee system was changed as the cohort intervention. No other organizational or procedural changes took place during the study period and no enhanced recovery programs were implemented. Proactive patient mobilization under full weight was driven by physiotherapists twicedaily according to their individual ability from day 1 after surgery. Criteria for discharge for all patients were: uncomplicated wound healing, flexion of 0-0-90 and ability to walk stairs on crutches.
The patients were operated either in intubation anesthesia (ITN) or spinal anesthesia. There was no change in the pain or wound care management. Postoperatively all patients received nonsteroidal antiinflammatory drugs (NSAIDs) (1-1-1 600 mg ibuprofen) as base medication and if required Targin (Mundipharma Deutschland GmbH & Co. KG, Frankfurt, Germany) (oxycodon + naloxon) (20/10 mg 1-0-1) upon individual requirement. None of the patients were catheterized or received blood transfusion. No intra-articular pain management was applied. Skin was closed with surgical staples. The wound was inspected daily.
Patients with potential risk of intensive care unit (ICU) requirements were operated on ata different hospital. As the patient data was derived from the hospital controlling system and not from the patients' medical records no information on complications was available.
The implants were applied according to the instructions for use. No change of the surgical technique took place. All patients were operated based on the concept of tibia first and according to the geometry of the implant.
Between July 2008 and May 2013, the standard of care for primary TKAs in this center was the LCS Knee System, which changed in June 2013 with the first implantation of the ATTUNE Knee System. Each cohort comprised a total of 88 consecutively enrolled patients. Patients were only included if no prior surgical procedures had been performed on the affected knee. Patients were excluded if the reported LOS was more than 15 and less than 5 days as due to privacy requirements these were provided only as a categorical value. Hence, 5 cases (3 LCS knees and 2 ATTUNE knees) with more than 15 days and 1 ATTUNE knee-case with less than 5 days LOS were excluded from further analyses.
The following base case characteristics, to support subsequent analysis, were documented: gender, age, availability or lack of support at home after discharge, previous contralateral TKA and ASA-risk categories. Due to data privacy regulations, date of TKA surgery was not provided in the dataset and age was provided in 10-year categories (41-50 years, 51-60 years, 61-70 year, 71-80 years). With disclosing date of procedure as well as date of birth and due to the pseudonymization of the retrospective data which did not allow for re-identification of the patients, the ethics committee of the Hamburg Medical Association did not require further approval.
The primary objective of this analysis was the change in LOS when switching from the LCS Knee System to the ATTUNE Knee System. Distributions and measures of central tendency were analyzed for both cohorts in order to evaluate the need to adjust for potential bias. Differences in independent variable distributions depending on the applied knee system were tested with the chisquared test and the Mann-Whitney U test. If a significant difference (5% level) was observed, an adjusted analysis of the difference in LOS via an ANOVA was to be conducted. If a comparable distribution of independent variables was observed a Welch two-sample t-test was to be performed.
Results

(97%) of 176 patients provided LOS information (85 ATTUNE knees, 85 LCS knees)
. Sixty percent of all TKApatients were women. Five percent of all patients were 41-50 years old, 13% 51-60 years, 30% 61-70 years, 44% 71-80 years, and 8% were older than 80 years. Eighteen percent of all TKApatients had a previous TKA in the contralateral knee. Mean LOS of the total cohort (N=176) was 9.3 days.
Both TKA cohorts revealed a similar gender distribution (see Figure 1 ) No significant differences could be observed (χ 2 =0.025, P=0.86). Minor differences were observed when comparing the age distribution of each TKA cohort. For the LCS Knee System more patients were observed in the age category 61-70 years, whereas ATTUNE knee patients were represented more often in the groups 51-60 and 71-80 years (see Figure 2) . However, differences were statistically non-significant (Mann-Whitney U test, P=0.80). When analyzing the dependent primary variable LOS the histogram shows a left shift of LOS for the ATTUNE Knee System(see Figure 5) .
Mean LOS was 10.4 (SD: 1.91) in the LCS knee group and 8.3 in the ATTUNE knee group (SD:1.79). This equals a LOS reduction of 20%. As both TKAcohorts showed no difference in distributions of independent patient variables, differences in LOS for both cohorts were analyzed using the Welch two-sample ttest. This analysis revealed a statistically significant reduction in LOS of 2.1 days (P<0.001; 95%CI: 2.7-1.6) when changing from LCS to the ATTUNE Knee System.
Discussion
The present study is the first analysis of LOS for TKApatients comparing the LCS and ATTUNE Knee Systems in Germany. Each cohort comprised of 85 evaluable patients, treated in one single center by a single surgeon team which applied consistent pre-, intra-and postoperative treatment and mobilization principles. All patients were mobilized according to their individual ability and as quickly as possible from day 1 after surgery. The patients were comparable with regard to baseline characteristics; age, gender, availability of home support, prior contralateral TKA, and perioperative ASA-classification categories. Hence, no adjustment was needed from a 17 With the exception of BMI, all relevant presurgical influencing factors could be analyzed in this study and no significant differences in variable distribution between cohorts were observed. Hence, it can be assumed that a bias due to sociodemographic or medical factors impacting the LOS difference is low. Length of stay reduction is influenced both by regional and by national health-care settings. This center is located in Hamburg and the state of residence (Bundesland) might have had an impact on LOS changes. In Bremen, for example, LOS reduced by 10% between 2007 and 2011, whereas in Hamburg and Thüringen a 4% reduction was reported in the same time period only, resulting in a negligible potential impact of the external regional setting on LOS. 18 From a national point of view an average national decline in LOS was reported for Germany. 19 Hence, we performed a sensitivity analysis for the potential impact of a parallel nationwide reduction in LOS. Due to data privacy regulations, exact date of surgery was not provided and only whole cohort periods could be analyzed (LCS Knee System, from July 2008 to May 2013 and ATTUNE Knee System, from May 2013 to June 2016). The average LOS in Germany for the implantation of bicondylar knee endoprothesis (DRG I44B) was 12.6 days during the LCS knee period and 11.3 days during the ATTUNE knee period resulting in an average national LOS decrease of 1.3 days. 19 Even when assuming 1.3 days of the total 2.1 day reduction observed resulted from national decrease, the remaining 0.8 days in LOS reduction in the ATTUNE knee cohort is highly significant (P<0.01) and represents a 38% greater reduction in LOS compared to the nationally reported decrease. As the decline of overall LOS in Hamburg was among the lowest reported, the assumption that a part of the LOS reduction was caused by the nationwide reduction is a very conservative sensitivity estimate. A comparative analysis of five different TKA prostheses identified device type as the major determinant with regard to change in cost-effectiveness ratios of TKA and impact on patient outcomes, such as function and quality of life. 20 The ATTUNE Knee System has shown significant improvements in several patient-reported outcome measures and is known to be associated with reduced patellofemoral pain and crepitus compared to other knee systems. [21] [22] [23] A US database study comparing a total of 1,178 ATTUNE knee patients and 5,707 Triathlon ® knee patients reported a significant reduction of unadjusted mean LOS reduction of 0.19 days from 3.13 days for the Triathlon ® knee patients to 2.94 days (P<0.001) for the ATTUNE knee patients. 24 In addition, the study showed that the adjusted odds for ATTUNE knee patients being discharged to a skilled nursing facility (SNF) were 39% lower than for Adjusted mean LOS for ATTUNE knee patients was 9.7 days (SD: 1.2) vs adjusted mean LOS of 13.7 days (SD: 1.9) for SIGMA knee patients. 26 Hence, the observed reduction of 20% in LOS in our study is in the scope of international results. Limitations of this study are the historic cohort design, the long study period, the data privacy related lack of the specified date of surgery and the use of the hospital controlling data base vs the medical patient records. Hence, next to the introduction of the ATTUNE Knee System, factors such as surgical setting, comorbidities and health system changes, might have influenced the observed LOS to some degree. However, as discussed above, these factors had a low impact only. A further minor limitation is the unavailability of date of surgery due to the data privacy regulations. Although our surgical team reported a fast early "learning curve", we could not statistically verify this with a surgery date based analysis.
Such an initially modest reduction in LOS after introducing the new ATTUNE Knee System followed by a more pronounced LOS reduction later was already reported by Huey et al where the first 10 ATTUNE knee cases obtained a lesser decrease in LOS compared to the subsequent procedures. 27 A strength of the present study is the unique application of only one device type as an institutional standard of care during each cohort study period. In addition, all surgeries during the study period were performed by a single unchanged surgical team consisting of only two skilled senior surgeons with a consistent treatment and proactive patient-adapted mobilization approach, which results in an exclusion of further potential bias. Furthermore, despite a long study period, TKA cohorts were comparable with regard to relevant patient variables.
National LOS of TKA patients in Germany of 11 days in 2016 is still high compared to other health-care systems. In 2011 Gaughan et al reported an average LOS of 6.9 days for the UK. 28 In the US 80% of all TKApatients are discharged within 3 days of TKA surgery. These variations are largely driven by the differences in the health-care systems, but the lower LOS observed in some countries highlights the potential to further reduce LOS in Germany. 29 The 2.1 day reduction observed in our study following the adoption of the ATTUNE knee is consistent with LOS reductions reported in studies from other geographical areas and might serve as an easy to implement factor to enhance further reductions in resource utilization while simultaneously guaranteeing advantageous patient outcomes. 23, 30 The potential benefits for the ATTUNE knee to achieve faster recovery and improve clinical outcomes are aligned to key aims of new hospital regulations; the Hospital Structure Act, including increased patient satisfaction, faster recovery and maximizing functional improvement. Furthermore the new guidelines for quality contracts by the German Federal Joint Committee (G-BA) state the choice of the implant is one of the relevant influencing factor of the treatment success which can be actively addressed by the hospital. 31 The observed trend in reducing LOS when applying the ATTUNE Knee System should be confirmed in further prospective studies. These studies should either employ a propensity-score based matched-pair comparison or,as a best case, use a randomized prospective control design in order to identify the particular impact of the applied prosthesis on LOS while also considering the selected mobilization approach.
Conclusion
When comparing the LCS Knee System and ATTUNE Knee System in two consecutive primary TKA patient cohorts in a German center with early and individual mobilization, similar sociodemographic and medical patient characteristics, LOS in ATTUNE knee patients was 2.1 days shorter than patients treated with LCS knee. Sensitivity analysis confirmed the robustness of the results. The observed trend in reducing LOS when applying the ATTUNE Knee System is in line with international results but should ideally be confirmed in prospective randomized studies.
